Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
Coronavirus channel feed
Trailing Eli Lilly by 12 days, Regeneron gets the FDA OK for their Covid-19 antibody cocktail
5 years ago
FDA+
AstraZeneca, Oxford on the defensive as skeptics dismiss 70% average efficacy for Covid-19 vaccine
5 years ago
It's official: Pfizer and BioNTech have submitted their Covid-19 vaccine to the FDA — and the agency circled a date for the adcomm
5 years ago
Pfizer and BioNTech are sending the first Covid-19 vaccine to the FDA today
5 years ago
Covid-19 roundup: WHO recommends against 'high cost' remdesivir, disappointing Gilead; EU deals with Pfizer/BioNTech, CureVac top $10B — report
5 years ago
Eli Lilly picks up another Covid-19 EUA as regulators wave through its Olumiant plus remdesivir combo
5 years ago
CEO Ugur Sahin: BioNTech and Pfizer will file for a Covid-19 vaccine EUA on Friday
5 years ago
FDA+
A new study breathes life into an all-but-dead approach to treating severe Covid-19
5 years ago
Alex Azar, refusing to acknowledge election results, says they're not working with Biden team on vaccine rollout
5 years ago
Covid-19 roundup: J&J enters PhIII with a two-dose regimen to play safe; AstraZeneca, Oxford tout promising data in elderly
5 years ago
Pfizer, BioNTech say vaccine is 95% effective, EUA submission 'within days'
5 years ago
Covid-19 roundup: FDA seeks vaccine adcomm meetings on Dec. 8-10 — report; Hahn to make all EUA data public
5 years ago
Pfizer CEO Albert Bourla says company crossed safety milestone for Covid-19 vaccine, EUA submission imminent
5 years ago
Covid-19 roundup: EU begins reviewing Moderna vaccine; CureVac and EU agree to 405M-dose deal
5 years ago
Moderna bolsters global hopes in Covid-19 vaccines, but big obstacles remain
5 years ago
Covid-19 roundup: Inovio finally gets PhII rolling — but there's still a clinical hold; Low cost vaccine enters PhI/II in India
5 years ago
J&J taps into BARDA well a third time to speed up its PhIII Covid-19 vaccine trial
5 years ago
Moderna says its vaccine is 94.5% effective at preventing Covid-19, appears to stop severe disease
5 years ago
R&D
Vaccine czar Slaoui expects Moderna's first Covid-19 data to come 'probably next week,' plans for 20M immunizations in December
5 years ago
Shortage of monkeys slowed down Eli Lilly's Covid-19 antibody partner. And it's a problem for everyone
5 years ago
R&D
China
CDER's Janet Woodcock: Pharma, regulators have lessons to learn from Covid-19
5 years ago
FDA+
Covid-19 roundup: J&J partners with UnitedHealth to hit the gas on vaccine trial enrollment; BioNTech CEO Ugur Sahin hits back at Trump while his vaccine gets cleared for China testing
5 years ago
Interferon beta-1a candidate for COPD advances to PhIII to test its potential against Covid-19
5 years ago
R&D
Covid-19 roundup: Political pressures at FDA continue post-election; Medicago takes GSK adjuvant into its first PhII/III
5 years ago
First page
Previous page
38
39
40
41
42
43
44
Next page
Last page